Oncotelic Therapeutics, Inc. SEC filings OTLC
Oncotelic Therapeutics, Inc. has 1,007 filings in SEC EDGAR's recent list, going back to Jul 19, 2005. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 17, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 18, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 22, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 18, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 22, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 23, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 22, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 20, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 24, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Jun 29, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 19, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 19, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 14, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 14, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 2, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 8, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 14, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 2, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 6, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 12, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 6, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 7, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Nov 13, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 8, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 8, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 13, 2013 | Sep 30, 2013 |
| 10-Q/A | Amended quarterly report | Oct 18, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | Aug 12, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 9, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | Nov 9, 2012 | Sep 30, 2012 |
| 10-Q | Quarterly report | Aug 13, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 11, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Nov 10, 2011 | Sep 30, 2011 |
| 10-Q | Quarterly report | Aug 12, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | May 13, 2011 | Mar 31, 2011 |
| 10-Q | Quarterly report | Nov 12, 2010 | Sep 30, 2010 |
| 10-Q | Quarterly report | Aug 13, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | May 14, 2010 | Mar 31, 2010 |
| 10-Q | Quarterly report | Nov 10, 2009 | Sep 30, 2009 |
| 10-Q | Quarterly report | Aug 13, 2009 | Jun 30, 2009 |
| 10-Q | Quarterly report | May 15, 2009 | Mar 31, 2009 |
| 10-Q | Quarterly report | Nov 7, 2008 | Sep 30, 2008 |
| 10-Q | Quarterly report | Aug 8, 2008 | Jun 30, 2008 |
| 10-Q | Quarterly report | May 12, 2008 | Mar 31, 2008 |
| 10-Q | Quarterly report | Nov 9, 2007 | Sep 30, 2007 |
| 10-Q | Quarterly report | Aug 7, 2007 | Jun 30, 2007 |
| 10-Q | Quarterly report | May 7, 2007 | Mar 31, 2007 |
| 10-Q | Quarterly report | Nov 3, 2006 | Sep 30, 2006 |
| 10-Q | Quarterly report | Aug 4, 2006 | Jun 30, 2006 |
| 10-Q | Quarterly report | May 3, 2006 | Mar 31, 2006 |
| 10-Q | Quarterly report | Nov 4, 2005 | Sep 30, 2005 |
| 10-Q | Quarterly report | Jul 29, 2005 | Jun 30, 2005 |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OTLC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aguora Hills, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 908259
- Former names
- MATEON THERAPEUTICS INC (until Mar 26, 2021); OXIGENE INC (until Jun 3, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.